2 assets in Acquired Thrombocytopenia

Therapeutic assets addressing Acquired Thrombocytopenia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Romiplostim Acquired Thrombocytopenia	Peking University People's Hospital	P2	CCC (53)
Tretinoin Acquired Thrombocytopenia	Peking University People's Hospital	P2	CCC (53)